TFF Pharmaceuticals Announces It Will Wind Down Operations
14 Novembre 2024 - 10:15PM
TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) today announced that the
Company has terminated its employees and will wind down its
operations. This decision was made at a special meeting of the
board of directors.
The board of directors appointed Craig R.
Jalbert, age 63, as the Company’s CEO, President, Chief Financial
Officer, Treasurer and Secretary, and sole member of the board. Mr.
Jalbert has served as a principal of the Foxborough, Massachusetts
accounting firm of Verdolino & Lowey, P.C. since 1987. For over
30 years he has focused his practice in distressed businesses and
has served, and continues to serve, in the capacities of officer
and director for numerous firms in their wind-down phases.
Forward Looking Statements
Statements made in this press release regarding
matters that are not historical facts are “forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. Because such statements are subject to risks
and uncertainties, actual results may differ materially from those
expressed or implied by such forward‐looking statements. Such
statements include, but are not limited to, statements regarding
our plans to wind down our operations or other statements not of
historical fact. Risks that could cause actual results to differ
from those expressed in these forward‐looking statements include:
the timing, progress and results of our planned wind down; general
market conditions; and other risks described in TFF
Pharmaceuticals’ filings with the Securities and Exchange
Commission under the heading “Risk Factors”. All forward‐looking
statements contained in this press release speak only as of the
date on which they were made and are based on management’s
assumptions and estimates as of such date. TFF Pharmaceuticals
undertakes no obligation to update such statements to reflect
events that occur or circumstances that exist after the date on
which they were made except as required by law.
Company Contact:Verdolino & Lowey, P.C.124
Washington Street, Suite 101Foxboro, MA. 02035Phone -
508-543-1720
TFF Pharmaceuticals (NASDAQ:TFFP)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
TFF Pharmaceuticals (NASDAQ:TFFP)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024